# Eurus Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eurus-therapeutics

- Industry: Biotechnology
- Headquarters: Fujisawa-shi, Japan
- Total disclosed funding: $0.4M
- Latest round: Series A (Mar 29, 2022)
- Investors on record: 2

## About

Established in 2021 and based in Kanagawa, Japan. Eurus therapeutics operates as a drug discovery venture. In March 2022, Eurus Therapeutics raised JPY 44 million in venture funding from Kyoto University Innovation Capital, Nissay Capital, and other investors. As of March 2022, the company is led by its CEO Takahito Nomi. 

The company specializes in the area of drug discovery.

## Funding rounds

- Series A, Mar 29, 2022, $0.4M — Nissay Capital, Kyoto University Innovation Capital

## Investors

- Nissay Capital (https://capitalatlas.ai/funds/nissay-capital) — Series A
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series A